Rn. Puglisi et al., THE EFFECT OF CYCLOSPORINE IN GUT ISCHEMIC-INJURY - A COMPUTERIZED MORPHOMETRIC AND ENZYMATIC ANALYSIS, Journal of pediatric surgery, 31(2), 1996, pp. 319-322
Purpose: Gut ischemia has been implicated in the pathogenesis of necro
tizing enterocolitis. Cyclosporine A (CSA), a potent immunosuppressant
, attenuates immune/inflammatory cellular reactions. CSA also might be
useful for inhibiting cellular immune responses involved in tissue is
chemia/reperfusion injury. The authors hypothesized that CSA would att
enuate inflammatory cellular changes associated with gut ischemic inju
ry and that these effects could be quantified by computerized morphome
try. Methods: Twenty Sprague-Dawley rats underwent 60 minutes of gut i
schemia by vascular occlusion of the superior mesenteric vessels. Afte
r 1 hour of reperfusion, the ischemic small bowel was harvested for hi
stopathological examination and computerized morphometry, as well as x
anthine oxidase (XO, U/mg protein) and maltase (MALT, mmol/L substrate
degraded/min/mg protein) assays. CSA (5 mg/kg/d subcutaneously) was g
iven to experimental animals (CSA, n = 10) for 5 days before ischemia,
and vehicle was given to controls (CON, n = 10). The computer morphom
etric parameters studied were: surface index (SI, mucosal surface leng
th per linear unit of intestine), average villous thickness (AVT), and
average villous height (AVH). Results: Results are provided in Table
1. Conclusion: The results of this study show that CSA may play a role
in attenuating ischemia/reperfusion injury in the gut. Enzymatic anal
ysis showed a beneficial role in the preservation of mucosal cell func
tion after gut ischemia/reperfusion injury, as demonstrated by an elev
ated maltose level. Computerized morphometry demonstrated significant
differences in all parameters in the experimental group, showing that
CSA does confer gut mucosal protection during ischemia. Copyright (C)
1996 by W.B. Saunders Company